Bank Of America Corp Sellas Life Sciences Group, Inc. Transaction History
Bank Of America Corp
- $1.17 Trillion
- Q4 2024
A detailed history of Bank Of America Corp transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 572 shares of SLS stock, worth $737. This represents 0.0% of its overall portfolio holdings.
Number of Shares
572
Previous 526
8.75%
Holding current value
$737
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding SLS
# of Institutions
38Shares Held
7.08MCall Options Held
1.8MPut Options Held
49.7K-
Vanguard Group Inc Valley Forge, PA2.29MShares$2.96 Million0.0% of portfolio
-
Anson Funds Management LP Dallas, TX1.19MShares$1.54 Million0.16% of portfolio
-
Geode Capital Management, LLC Boston, MA734KShares$946,2740.0% of portfolio
-
Brooklyn Fi, LLC New York, NY595KShares$767,4450.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il485KShares$626,0580.0% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $26.5M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...